US1266501006 - Common Stock
Dividend-paying stocks consistently outperform those that don't pay a dividend.
Which S&P500 stocks are moving on Thursday?
Thursday's session: top gainers and losers in the S&P500 index
Curious about the S&P500 stocks that are gapping on Thursday? Explore the gap up and gap down stocks in the S&P500 index during today's session.
CVS earnings call for the period ending September 30, 2024.
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Wednesday to find the gap up and gap down stocks in today's session.
Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.
US health insurers focused on the Medicare market jumped on the expectation that the second Trump administration will pay higher rates to companies that provide private versions of the US health program for seniors.
CVS Health Corp.’s new Chief Executive Officer David Joyner offered investors no guidance on the company’s expected financial performance for 2024 or 2025 in Wednesday’s earnings report, the first of his tenure.
Financial Highlights Third quarter total revenues increased to $95.4 billion, up 6.3% compared to the prior year Third quarter GAAP diluted EPS of $0.07 and...
This leading REIT could be an attractive dividend play again.
A pharmaceutical scientist was accused of making $617,000 in illegal profits from trading on a secret tip he got from his domestic partner about plans by drug store chain CVS Health Corp. to buy Oak Street Health Inc., where she was a senior executive.
The GLP-1 drama continues at Hims & Hers.
We've also got a look at genetic testing company 23andMe .
If you buy these stocks, you might be in for serious disappointment when they underperform.